Ropes & Gray Represents Perceptive Advisors in Rhythm Pharmaceuticals Convertible Preferred Stock Investment
April 03, 2024
April 03, 2024
BOSTON, Massachusetts, April 3 -- Ropes and Gray, a law firm, issued the following news:
Ropes & Gray advised Perceptive Advisors LLC in its investment in Rhythm Pharmaceuticals, Inc., a biopharmaceutical company focused on treatments for rare neuroendocrine diseases including disorders that lead to severe obesity.
Perceptive led the purchase of $150 million in series A convertible preferred stock. Rhythm intends to use the proceeds of the sale to fund its clinical . . .
Ropes & Gray advised Perceptive Advisors LLC in its investment in Rhythm Pharmaceuticals, Inc., a biopharmaceutical company focused on treatments for rare neuroendocrine diseases including disorders that lead to severe obesity.
Perceptive led the purchase of $150 million in series A convertible preferred stock. Rhythm intends to use the proceeds of the sale to fund its clinical . . .